Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

E. Elez, A. Hendlisz, T. Delaunoit, J. Sastre, A. Cervantes, R. Varea, G. Chao, J. Wallin, J. Tabernero

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences